These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19732809)

  • 1. Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease.
    Lefebvre T; Dehennaut V; Guinez C; Olivier S; Drougat L; Mir AM; Mortuaire M; Vercoutter-Edouart AS; Michalski JC
    Biochim Biophys Acta; 2010 Feb; 1800(2):67-79. PubMed ID: 19732809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.
    Copeland RJ; Bullen JW; Hart GW
    Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E17-28. PubMed ID: 18445751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.
    Tramutola A; Sharma N; Barone E; Lanzillotta C; Castellani A; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Gaetani S; Cassano T; Perluigi M; Di Domenico F
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3309-3321. PubMed ID: 30031227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
    Park J; Lai MKP; Arumugam TV; Jo DG
    Neuromolecular Med; 2020 Jun; 22(2):171-193. PubMed ID: 31894464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of O-GlcNAc in chronic diseases of aging.
    Banerjee PS; Lagerlöf O; Hart GW
    Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.
    Pinho TS; Correia SC; Perry G; Ambrósio AF; Moreira PI
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2048-2059. PubMed ID: 30412792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc modification in diabetes and Alzheimer's disease.
    Dias WB; Hart GW
    Mol Biosyst; 2007 Nov; 3(11):766-72. PubMed ID: 17940659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAcylation in cellular functions and human diseases.
    Yang YR; Suh PG
    Adv Biol Regul; 2014 Jan; 54():68-73. PubMed ID: 24184094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose.
    Housley MP; Udeshi ND; Rodgers JT; Shabanowitz J; Puigserver P; Hunt DF; Hart GW
    J Biol Chem; 2009 Feb; 284(8):5148-57. PubMed ID: 19103600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory O-GlcNAcylation sites on FoxO1 are yet to be identified.
    Fardini Y; Perez-Cervera Y; Camoin L; Pagesy P; Lefebvre T; Issad T
    Biochem Biophys Res Commun; 2015 Jun; 462(2):151-8. PubMed ID: 25944660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
    Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
    Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [O-GlcNAc glycosylation and regulation of cell signaling].
    Issad T
    Med Sci (Paris); 2010; 26(8-9):753-9. PubMed ID: 20819714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protein O-GlcNAcylation and regulation of cell signalling: involvement in pathophysiology].
    Issad T; Pagesy P
    Biol Aujourdhui; 2014; 208(2):109-17. PubMed ID: 25190571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.
    Hart GW; Slawson C; Ramirez-Correa G; Lagerlof O
    Annu Rev Biochem; 2011; 80():825-58. PubMed ID: 21391816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging link between O-GlcNAcylation and neurological disorders.
    Ma X; Li H; He Y; Hao J
    Cell Mol Life Sci; 2017 Oct; 74(20):3667-3686. PubMed ID: 28534084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
    Du P; Zhang X; Lian X; Hölscher C; Xue G
    J Alzheimers Dis; 2024; 97(3):1051-1068. PubMed ID: 38250776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation Negatively Regulates Cardiomyogenic Fate in Adult Mouse Cardiac Mesenchymal Stromal Cells.
    Zafir A; Bradley JA; Long BW; Muthusamy S; Li Q; Hill BG; Wysoczynski M; Prabhu SD; Bhatnagar A; Bolli R; Jones SP
    PLoS One; 2015; 10(11):e0142939. PubMed ID: 26565625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAcylation: a bridge between glucose and cell differentiation.
    Sun C; Shang J; Yao Y; Yin X; Liu M; Liu H; Zhou Y
    J Cell Mol Med; 2016 May; 20(5):769-81. PubMed ID: 26929182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.